Eating oily fish may boost bowel cancer survival: study

Eating oily fish may boost bowel cancer survival: studyPeople with bowel cancer may improve their survival chances by eating a lot of omega 3 fatty acids found in oily fish like tuna and salmon, a study suggested Wednesday. Analysis of data from more than 170,000 people in the United States revealed that among 1,659 who developed bowel cancer, there was a strong correlation between higher omega 3 intake and lower risk of death, it said. "Compared with patients who consumed less than 0.1 grammes (0.004 ounces) of omega 3 fatty acids daily, those who consumed at least 0.3 grammes daily after their diagnosis, had a 41 percent lower risk of dying from their disease," said a statement on the findings published in the British journal Gut.

Go to Source

Hunger, looting and now suspected cholera hit South Sudan

A displaced South Sudanese family is seen camping at the WFP compound in Juba, South SudanBy Tom Miles GENEVA (Reuters) – Dozens of people have fallen ill with suspected cholera in South Sudan&;s capital of Juba, while a U.N. food warehouse was looted and destroyed, incurring $20 million of damage, the United Nations said on Tuesday. "We expect a huge humanitarian crisis. Cholera is a type of acute watery diarrhoea which kills fewer than 1 percent of sufferers if there is proper treatment with oral rehydration salts, according to the World Health Organisation.

Go to Source

Henderson calls for investor vote on Bayer’s takeover of Monsanto

A Monsanto logo is pictured in the company headquarters in MorgesBy Sinead Cruise LONDON (Reuters) – Henderson Global Investors, a minority investor in Bayer has demanded a vote on the firm&;s $64 billion-plus proposed takeover of Monsanto, which it said threatened the long-term strength of the German chemicals group. Asim Rahman, European equities fund manager at Henderson, one of Bayer&039;s 20 largest investors with a 0.7 percent stake, said the bid for the U.S. seeds company represented "a major departure from a strategy of focus and integration of existing acquisitions" that Bayer had consistently communicated to the market for a number of years. Bayer announced a sweetened $125-a-share offer for Monsanto, the largest all-cash takeover bid on record, on July 14 in an effort to entice its reluctant management to give the German company full access to its books.

Go to Source

1 3 4 5 6 7 12